Breaking News

UCB, biOasis In Research Pact

December 3, 2012

To use Transcend technology for drug delivery to the brain

biOasis Technologies and UCB, based in Brussels, have entered into a research collaboration to evaluate biOasis’ Transcend technology for the delivery of therapeutic compounds to the brain. biOasis will conduct certain experiments using its Transcend technology as it relates to the delivery of therapeutic compounds owned by UCB for CNS disorders. Financial Terms were not disclosed.
 
"UCB is a highly respected biopharmaceutical company with a broad global presence and a deep pipeline. We’re very pleased to be commencing this collaboration with UCB whom we believe have some tremendous targets for our Transcend vector," said Rob Hutchison, chief executive officer, biOasis Technologies. "The interest from within the industry on our Transcend technology is clearly widening and this agreement with UCB is a prime example of that. The work will start over the next few months and carry into the New Year. We are looking forward to working with the UCB scientists to successfully achieve the objectives we have set out in agreement."
 

Related Contract Manufacturing:

blog comments powered by Disqus
  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Major Regulatory Changes in China to Impact Western Drug Developers

    Major Regulatory Changes in China to Impact Western Drug Developers

    David Deere, PaizaBio||January 28, 2016
    PaizaBio reports on drug development and manufacturing strategies

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.